|
🐜
|
SF3B1 mutations constitute a novel therapeutic target in breast cancer
10 auth.
S. Maguire,
A. Leonidou,
Patty T. Wai,
C. Marchiò,
C. Ng,
A. Sapino,
...
A. Salomon,
J. Reis-Filho,
B. Weigelt,
R. Natrajan
|
7 |
2014 |
7
🐜
|
|
🐜
|
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
23 auth.
C. Ng,
L. Martelotto,
A. Gauthier,
H. Wen,
S. Piscuoglio,
R. Lim,
C. Cowell,
P. Wilkerson,
Patty T. Wai,
D. Rodrigues,
...
L. Arnould,
F. Geyer,
S. Bromberg,
M. Lacroix-Triki,
F. Penault-Llorca,
S. Giard,
X. Sastre-Garau,
R. Natrajan,
L. Norton,
P. Cottu,
B. Weigelt,
A. Vincent-Salomon,
J. Reis-Filho
|
6 |
2015 |
6
🐜
|
|
🐜
|
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
27 auth.
R. Natrajan,
P. Wilkerson,
C. Marchiò,
S. Piscuoglio,
C. Ng,
Patty T. Wai,
Maryou B. K. Lambros,
E. Samartzis,
K. Dedes,
J. Frankum,
I. Bajrami,
Alicja Kopec,
A. Mackay,
R. A’Hern,
K. Fenwick,
...
I. Kozarewa,
Jarle Hakas,
C. Mitsopoulos,
D. Hardisson,
C. Lord,
Chandan Kumar-Sinha,
A. Ashworth,
B. Weigelt,
A. Sapino,
A. Chinnaiyan,
C. Maher,
J. Reis-Filho
|
6 |
2014 |
6
🐜
|
|
🐜
|
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts
29 auth.
Michele Bortolomeazzi,
Mohamed Reda Keddar,
L. Montorsi,
A. Acha-Sagredo,
Lorena Benedetti,
D. Temelkovski,
Subin Choi,
N. Petrov,
K. Todd,
Patty T. Wai,
Johannes Kohl,
Tamara Denner,
E. Nye,
R. Goldstone,
S. Ward,
...
G. Wilson,
M. Al Bakir,
C. Swanton,
S. John,
J. Miles,
Banafshé Larijani,
V. Kunene,
E. Fontana,
H. Arkenau,
Peter J. Parker,
M. Rodríguez-Justo,
K. Shiu,
J. Spencer,
F. Ciccarelli
|
6 |
2021 |
6
🐜
|
|
🐜
|
A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers
33 auth.
R. Natrajan,
A. Mackay,
Maryou B. K. Lambros,
B. Weigelt,
P. Wilkerson,
Elodie Manié,
A. Grigoriadis,
R. A’Hern,
P. van der Groep,
I. Kozarewa,
T. Popova,
O. Mariani,
S. Turajlic,
S. Furney,
R. Marais,
...
Daniel-Nava Rodruigues,
Adriana C Flora,
Patty T. Wai,
Vidya Pawar,
S. McDade,
J. Carroll,
D. Stoppa-Lyonnet,
A. Green,
I. Ellis,
C. Swanton,
P. V. van Diest,
O. Delattre,
C. Lord,
W. Foulkes,
A. Vincent-Salomon,
A. Ashworth,
M. Stern,
J. Reis-Filho
|
6 |
2012 |
6
🐜
|
|
🐜
|
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome
7 auth.
Lukas Krasny,
Philip Bland,
Naoko Kogata,
Patty T. Wai,
Beatrice A. Howard,
R. Natrajan,
...
Paul H. Huang
|
6 |
2018 |
6
🐜
|
|
🐜
|
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
20 auth.
K. Naidoo,
Patty T. Wai,
S. Maguire,
F. Daley,
S. Haider,
D. Kriplani,
James Campbell,
H. Mirza,
A. Grigoriadis,
A. Tutt,
...
P. Moseley,
T. Abdel-Fatah,
S. Chan,
S. Madhusudan,
Emad A Rhaka,
I. Ellis,
C. Lord,
Yinyin Yuan,
A. Green,
R. Natrajan
|
5 |
2017 |
5
🐜
|
|
🐜
|
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
19 auth.
J. Wong,
Jason R. Todd,
M. Finetti,
F. McCarthy,
Malgorzata Broncel,
S. Vyse,
Maciej T. Luczynski,
S. Crosier,
K. Ryall,
Kate Holmes,
...
L. Payne,
F. Daley,
Patty T. Wai,
Andrew Jenks,
B. Tanos,
A. Tan,
R. Natrajan,
D. Williamson,
Paul H. Huang
|
5 |
2016 |
5
🐜
|
|
🐬
|
Comparative proteomic assessment of matrisome enrichment methodologies
Lukas Krasny,
A. Paul,
Patty T. Wai,
Beatrice A. Howard,
R. Natrajan,
Paul H. Huang
|
5 |
2016 |
5
🐬
|
